FDA approves Narcan for OTC opioid overdose reversal.
TL;DR Summary
The FDA has approved the over-the-counter sale of Narcan, the nasal spray brand name for the drug naloxone, which can reverse opioid overdoses. Emergent BioSolutions, the drug company that produces Narcan, hopes to make it available on store shelves and online by late summer. The approval comes as the U.S. continues to see a staggering number of opioid-related deaths, with 101,751 reported fatal overdoses in the 12-month period ending in October. The specific dose approved for over-the-counter sales is the 4 milligram (mg) naloxone hydrochloride nasal spray.
- The FDA has approved the overdose-reversing drug Narcan for over-the-counter sales NPR
- F.D.A. Approves Narcan for Over-the-Counter Sales The New York Times
- FDA approves first over-the-counter drug for opioid overdose reversal WGN News
- FDA approves first over-the-counter opioid overdose antidote Narcan CNN
- Opioid overdose drug Narcan approved for over-the-counter use by FDA Fox Business
Reading Insights
Total Reads
0
Unique Readers
10
Time Saved
2 min
vs 3 min read
Condensed
81%
448 → 87 words
Want the full story? Read the original article
Read on NPR